caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1568454080

Neil MorgansteinMD

Hematology-OncologySummit, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,696
Unique beneficiaries
—
Total services
4,477
Distinct HCPCS
12
Medicare payment
$273K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 301 Hematology-Oncology providers in NJ — above median (cohort median 3,501).
REFERRAL NETWORK

Where Neil Morganstein's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 38 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Alexander Volvovsky
Diagnostic Radiology · New York, NY
63249
MORSE, SOPHIE63400
Neil Horner
Diagnostic Radiology · Summit, NJ
58242
Terrence Lee
Diagnostic Radiology · New Providence, NJ
57212
Clifford Sales
Vascular Surgery · Westfield, NJ
56273
Erika Berman
Diagnostic Radiology · Berkeley Heights, NJ
43201
Miles Levin
Pathology · Summit, NJ
42203
SNIECKUS, PETER38127
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
37126
SALOMON, AMIR32143
William Matuozzi
Diagnostic Radiology · Berkeley Heights, NJ
2894
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
28128
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
864
Beneficiaries
—
Total drug cost
$6.9M
Distinct drugs
25
Brand share
69.3%
Top prescribed drugs
Acalabrutinib Maleate83 claims
Rivaroxaban81 claims
Ruxolitinib Phosphate65 claims
Valacyclovir Hcl52 claims
Apixaban50 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
36
By payment type
Consulting Fee$803
Food and Beverage$696
Education$17